| Literature DB >> 34345565 |
Katarina B Dakay1, Idrees Azher2, Ali Mahta3, Karen Furie3, Shadi Yaghi3, Shawna M Cutting3.
Abstract
Background Multifocal convexity subarachnoid hemorrhage (cSAH) has generally been described in the setting of traumatic brain injury, however, it has also been reported in the absence of trauma in conditions such as with reversible cerebral vasoconstriction syndrome. We describe the clinical and radiographic characteristics of multifocal cSAH in an academic center. Methods We analyzed our single-center retrospective database of nontraumatic convexity subarachnoid hemorrhage from January 2015-January 2018. Convexity subarachnoid hemorrhage was defined as blood in one or more cortical sulci in the absence of trauma; patients with blood in the cisterns or Sylvian fissure were excluded. Multifocal location was defined as at least two distinct foci of hemorrhage occurring in two or more lobes. Clinical and neuroimaging data were collected. Results Out of 70 total patients with convexity subarachnoid hemorrhage, 13 cases were of multifocal convexity subarachnoid hemorrhage, occurring in 18.6% of all cases. The mean age was 58 years (SD = 14.7). Eleven patients were female. Seven patients had reversible cerebral vasoconstriction syndrome (RCVS)/posterior reversible encephalopathy syndrome (PRES), two had cerebral amyloid angiopathy (CAA), three had intrinsic coagulopathy, and one patient had endocarditis as the etiology of multifocal cSAH. Headache was the most common complaint, in eight (61.5%) patients. Conclusion Multifocal cSAH occurs in approximately 18.6% of all cSAH and can occur in the absence of trauma. In our larger cohort of all cSAH, CAA was the most common cause; however, multifocal cSAH is more commonly caused by RCVS/PRES spectrum. Clinicians should be aware that multifocal cSAH can occur in the absence of trauma, and may be a harbinger of RCVS/PRES, particularly in young patients with thunderclap headaches.Entities:
Keywords: cerebral amyloid angiopathy; convexity subarachnoid hemorrhage; mri- magnetic resonance imaging; reversible cerebral vasoconstriction syndrome; subarachnoid hemorrhage
Year: 2021 PMID: 34345565 PMCID: PMC8325476 DOI: 10.7759/cureus.16091
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Case Series
cSAH=convexity subarachnoid hemorrhage; RCVS=reversible cerebral vasoconstriction syndrome; CAA=cerebral amyloid angiopathy; mRS=modified Rankin scale; PRES=posterior reversible encephalopathy syndrome
| Patient | Age | Sex | Medical Comorbidities | Clinical Presentation | Onset to Imaging (days) | Location of cSAH | Etiology of cSAH | Precipitating or Aggravating Factors (if known) | Outcome |
| Patient 1 | 65 | F | Hypertension, diabetes | Thunderclap headache; confusion | 1 | Bilateral parietal and occipital lobes; interhemispheric fissure | RCVS | Serotonin-norepinephrine reuptake inhibitor | Discharged home; mRS of 1 at 90d |
| Patient 2 | 54 | F | Hyperlipidemia | Thunderclap headache with nuchal rigidity | 0 | Bilateral parietal lobes | RCVS | Valsalva | Discharged home; lost to follow-up |
| Patient 3 | 73 | F | Hypertension, diabetes, dementia, coronary artery disease, atrial fibrillation (not anticoagulated) | Altered mental status; lethargy and difficulty walking | 4 | Parietal and frontal lobes | CAA | N/A | Readmission for urinary infection; lost to follow-up |
| Patient 4 | 49 | F | Migraine, diabetes, COPD | Thunderclap headache | 7 | Bilateral parietal and occipital lobes | RCVS | Decongestant use | Discharged home; mRS of 0 at 90 days, returned to work |
| Patient 5 | 58 | M | Diabetes, hyperlipidemia, renal and hepatic disease | Thunderclap headache; diffuse numbness and tremor | 6 | Right frontal and left parietal | Thrombocytopenia due to cirrhosis | Aspirin | mRS of 1 at 90 days |
| Patient 6 | 57 | F | Cancer, migraine, hypertension, COPD | Thunderclap headache | 0 | Multifocal | RCVS | Emotional stress/heated argument | mRS 0 at 90 days |
| Patient 7 | 83 | M | Hypertension, diabetes, atrial fibrillation | Left arm tingling and epistaxis | 1 | Multifocal | Aplastic anemia | Aspirin | Lost to follow-up |
| Patient 8 | 22 | F | Prior aneurysmal subarachnoid hemorrhage | Abdominal pain and fever | 2-3 | Frontal, parietal and occipital lobes | Endocarditis | N/A | Lost to follow-up |
| Patient 9 | 75 | F | Coronary artery disease, renal disease | Altered mental status after knee surgery | 4 | Frontal and parietal lobes | CAA | Prophylactic dose lovenox | Discharged to rehab; mRS 3 at 90 days |
| Patient 10 | 55 | F | Acute lymphocytic leukemia, idiopathic thrombocytopenic purpura, hyperlipidemia | Headache; known leukemia | 2 | Multifocal | Thrombocytopenia due to idiopathic thrombocytopenic purpura | N/A | Transferred to another hospital; lost to follow-up |
| Patient 11 | 63 | F | Hypertension, epilepsy | Confusion, blurry vision, headache with nausea/vomiting | 0 | Multifocal | PRES | Hypertension | Readmitted within 90 days for hypertensive urgency; mRS 1 at 90 days |
| Patient 12 | 52 | F | Hypertension | Severe headache with nausea/vomiting; scotomas | 3 | Interhemispheric fissure, parietal | RCVS | Marijuana | mRS of 2 at 90 days |
| Patient 13 | 56 | F | Hypertension, prior stroke, prior breast cancer | Severe headache, weakness | 0 | Multifocal | RCVS | Selective serotonin reuptake inhibitor | Developed subsequent intracerebral hemorrhage requiring decompressive hemicranectomy; mRS of 4 at 90 days |
Figure 1Multifocal Convexity Subarachnoid Hemorrhage
Fluid-attenuated inversion recovery (FLAIR) sequence demonstrates two distinctive areas of subarachnoid hemorrhage (blue arrows).
Figure 2Angiography
Angiography in a patient with RCVS demonstrates vasoconstriction in the left superior cerebellar artery (yellow arrow) and left posterior cerebral artery (blue arrow).
RCVS=reversible cerebral vasoconstriction syndrome
Incidence of Multifocal Convexity Subarachnoid Hemorrhage in Prior Case Series
cSAH=convexity subarachnoid hemorrhage; CAA=cerebral amyloid angiopathy; RCVS=reversible cerebral vasoconstriction syndrome; PRES=posterior reversible encephalopathy syndrome; NR=not reported
| Author (Year) | Number of total patients | Most common cause of cSAH (N) | Number of multifocal cSAH | N (Percent) of patients with CAA as etiology | N (Percent) w RCVS/PRES as etiology |
| Spitzer (2005) | 12 | PRES/RCVS (4) | 1 (8%) | 0(0%) | 4 (25%) |
| Refai (2008) | 20 | RCVS/PRES (7) | 3 (15%) | 0 (0%) | 11 (54%) |
| Kumar (2010) | 29 | RCVS/PRES (11) | 5 (17%) | 10 (35%) | 11 (38%) |
| Beitzke (2011) | 24 | NR | 12 (50%) | 5 (21%) | NR |
| Bruno (2013) | 34 | RCVS/PRES (13) | 3 (9%) | 13 (38%) | 7 (20%) |